Gouvernance Ironwood Pharmaceuticals, Inc.

IRWD

US46333X1081

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 07/08/2026			Varia. 5j.	Varia. 1 janv.
4,320 ^USD	+1,41%		+2,13%	+28,19%

06/08	Transcript : Ironwood Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026
06/08	Ironwood Pharmaceuticals, Inc. relève ses prévisions de résultats pour l'exercice 2026	CI

Comité Exécutif: Ironwood Pharmaceuticals, Inc.

Dirigeant

Fonctions occupéesDepuis

Thomas McCourt

68 ans

Chief Executive Officer	12/03/2021
President	01/04/2019

Ronald Silver

44 ans

Comptroller/Controller/Auditor	01/04/2019
Director of Finance/CFO	15/05/2026

John Minardo

51 ans

General Counsel	03/08/2021
Corporate Secretary	03/08/2021

Rosario Lobrutto

Chief Tech/Sci/R&D Officer

01/04/2024

Jeff Ruberti

Investor Relations Contact	01/05/2026
Public Communications Contact	01/05/2026

Jeffrey Silber

Chief Tech/Sci/R&D Officer

20/07/2026

Composition du Conseil d'Administration: Ironwood Pharmaceuticals, Inc.

Administrateur

ComitésDepuis

Julie McHugh

61 ans

Audit Committee	01/04/2019
Governance Committee	01/04/2019
Nominating Committee	01/04/2019
Governance Committee Chair	01/01/2017
Nominating Committee Chair	01/01/2017

Jay Shepard

68 ans

Audit Committee
Governance Committee
Nominating Committee
Compensation Committee

Jon Duane

67 ans

Governance Committee	01/04/2019
Nominating Committee	01/04/2019
Compensation Committee Chair
HR Committee Chair

Alexander Denner

56 ans

Finance Committee	01/01/2009
Governance Committee Chair
Nominating Committee Chair

Mark Currie

71 ans

Compensation Committee	01/01/2019
HR Committee	01/01/2019

Marla Kessler

56 ans

Compensation Committee	01/04/2019
HR Committee	01/04/2019

Catherine Moukheibir

66 ans

Audit Committee Chair

Thomas McCourt

68 ans

Compensation Committee

06/03/2023

Dernières Nominations: Ironwood Pharmaceuticals, Inc.

14/07	Ironwood Pharmaceuticals, Inc. annonce des changements au sein de sa direction	CI
13/05	Ironwood Pharmaceuticals, Inc. annonce des changements au sein de sa direction, effectifs au 15 mai 2026	CI
24/02	Kyverna Therapeutics, Inc. annonce des changements au sein de son conseil d'administration et de ses comités	CI
10/10/25	Ironwood Pharmaceuticals, Inc. annonce la démission d'Andrew Dreyfus du Conseil d'administration, effective au 1er novembre 2025	CI
30/01/25	Ironwood Pharmaceuticals supprime la moitié de ses effectifs, baisse les essais de phase 2 de son médicament et publie ses perspectives pour 2025	MT
29/01/25	Ironwood Pharmaceuticals, Inc. annonce des changements au niveau de la direction	CI
06/12/24	Beam Therapeutics nomme Sravan Emany directeur financier	MT

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Ironwood Pharmaceuticals, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Michael Shetzline

Chief Tech/Sci/R&D Officer

28/01/2019

20/07/2026

Andrew Dreyfus

Director/Board Member	01/04/2016	01/11/2025
Independent Dir/Board Member	01/04/2016	01/11/2025

Beth Calitri

Public Communications Contact

01/01/2019

01/04/2025

Jason Rickard

Chief Operating Officer	01/01/2014	12/05/2023
Director of Finance/CFO	01/07/2015	01/07/2018
Corporate Officer/Principal	01/01/2012	01/01/2014

Edward Owens

Director/Board Member	01/03/2013	01/06/2022
Independent Dir/Board Member	01/03/2013	01/06/2022

Lawrence Olanoff

Director/Board Member	01/04/2015	01/06/2022
Independent Dir/Board Member	01/04/2015	01/06/2022

Gina Consylman

Comptroller/Controller/Auditor	19/02/2021	02/07/2021
Director of Finance/CFO	14/09/2017	02/07/2021
Treasurer	-	08/07/2019

Meredith Kaya

Investor Relations Contact	-	01/06/2021
Public Communications Contact	-	01/06/2021

Mark Mallon

Director/Board Member	01/04/2019	12/03/2021
Chief Executive Officer	01/04/2019	12/03/2021

Kelly MacDonald

Comptroller/Controller/Auditor	08/07/2019	19/02/2021
Corporate Officer/Principal	01/09/2013	08/07/2019

Conor Kilroy

General Counsel	01/04/2019	01/02/2021
Corporate Secretary	01/04/2019	01/02/2021

Halley Gilbert

Chief Administrative Officer	30/05/2019	01/02/2020
General Counsel	01/01/2008	01/02/2020
Corporate Secretary	01/02/2014	01/02/2020

Terry McGuire

Director/Board Member	01/01/1998	01/01/2015
Chairman	01/01/2015	01/04/2019
Independent Dir/Board Member	01/01/1998	01/04/2019

Amy Schulman

Director/Board Member	01/01/2017	01/04/2019
Independent Dir/Board Member	01/01/2017	01/04/2019

Peter Hecht

Director/Board Member	01/01/1998	01/04/2019
Chief Executive Officer	01/01/1998	01/04/2019
Founder	01/01/1998	01/04/2019

Christopher Wright

Corporate Officer/Principal

01/03/2017

01/04/2019

Douglas Williams

Director/Board Member	01/06/2014	01/04/2019
Independent Dir/Board Member	01/06/2014	01/04/2019

Marsha Fanucci

Director/Board Member	01/01/2009	01/04/2019
Independent Dir/Board Member	01/01/2009	01/04/2019

William I. Huyett

Chief Operating Officer

01/12/2017

01/03/2019

Brian M. Cali

Chief Tech/Sci/R&D Officer	-	-
Founder	01/01/1998	01/03/2019
Corporate Officer/Principal	01/01/1998	29/07/2015

Jonathan Rosin

Human Resources Officer

01/01/2012

01/03/2019

Michael Mendelsohn

Chief Tech/Sci/R&D Officer

01/12/2014

01/12/2018

Mark Ragosa

Investor Relations Contact	01/09/2016	01/05/2018
Corporate Officer/Principal	01/09/2016	01/02/2018

Thomas Graney

Director of Finance/CFO

02/09/2014

13/09/2017

Christopher T. Walsh

Director/Board Member	01/07/2003	31/05/2017
Independent Dir/Board Member	20/06/2011	31/05/2017

George Conrades

Director/Board Member	01/12/2005	01/04/2016
Independent Dir/Board Member	20/06/2011	01/04/2016

Jeffrey M. Johnston

Chief Tech/Sci/R&D Officer

01/09/2005

01/01/2016

Bryan Roberts

Director/Board Member	01/01/2001	01/01/2016
Chairman	20/06/2011	01/01/2015
Independent Dir/Board Member	20/06/2011	01/01/2016

Joe C. Cook

Director/Board Member	20/06/2011	03/06/2015
Chairman	05/01/1998	20/06/2011
Founder	24/07/2009	03/06/2015
Independent Dir/Board Member	20/06/2011	03/06/2015

David Ebersman

Director/Board Member	15/09/2009	03/06/2015
Independent Dir/Board Member	20/06/2011	03/06/2015

Michelle Robertson

Corporate Officer/Principal

01/01/2012

01/01/2015

Rhonda Chicko

Comptroller/Controller/Auditor

01/01/2005

01/01/2015

James DeTore

Chief Administrative Officer	17/04/2012	01/10/2014
Director of Finance/CFO	01/01/2003	17/06/2011
Corporate Officer/Principal	17/06/2011	01/11/2014

Lisa Adler

Public Communications Contact

02/09/2014

David Evans Shaw

Director/Board Member	01/01/2004	03/06/2014
Independent Dir/Board Member	20/06/2011	03/06/2014

Lisa Fiering

Corporate Officer/Principal

01/11/2011

01/03/2014

Robert Lippe

Chief Operating Officer

01/01/2011

01/02/2014

Abraham Ceesay

Sales & Marketing

01/01/2010

02/01/2014

Christina Isacson

Corporate Officer/Principal

01/07/2007

01/09/2013

John Crowley

Comptroller/Controller/Auditor

01/03/2012

01/09/2013

Michael L. Hall

Chief Tech/Sci/R&D Officer

21/08/2013

Gina Bornino Miller

Director/Board Member	20/10/2009	09/06/2011
Founder	20/10/2009	09/06/2011

Stephen Knight

Director/Board Member

01/01/2004

02/02/2010

John J. Talley

Corporate Officer/Principal

01/01/2002

01/01/2008

Ricky Sun

Corporate Officer/Principal

01/01/2002

01/08/2004

James O'Mara

Corporate Officer/Principal

01/10/2001

Peter Yorgey

Corporate Officer/Principal

01/01/2000

G. Todd Milne

Founder	20/10/2009	-
Corporate Officer/Principal	05/01/1998	-

Eric F. Summers

Founder

20/06/2011

Niels Borgstein

Corporate Officer/Principal

Angelika Fretzen

Corporate Officer/Principal

Susan Brady

Investor Relations Contact	20/06/2011	23/05/2012
Public Communications Contact	02/12/2009	-

Trista Morrison

Public Communications Contact

Tony Colasin

Corporate Officer/Principal

Eduardo Martinez

Corporate Officer/Principal

Mary T. Conway

Investor Relations Contact	-	-
Public Communications Contact	-	-

Vineeta Belanger

Corporate Officer/Principal

Sharon DeBacco

Public Communications Contact	-	-
Corporate Officer/Principal	-	01/10/2014

Kevin T. Sprott

Corporate Officer/Principal

Bart Henderson

Corporate Officer/Principal

Jean George

Director/Board Member

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	11
Femme	3

Dont comité exécutif

Homme	6
Femme	0

Dont Administrateurs

Homme	5
Femme	3

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Ironwood Pharmaceuticals, Inc. est une société de biotechnologie qui développe et commercialise des traitements susceptibles de changer la vie des personnes atteintes de maladies gastro-intestinales (GI) et de maladies rares. Elle se concentre sur le développement et la commercialisation de produits destinés au traitement des troubles gastro-intestinaux dans des domaines où les besoins non satisfaits sont importants. LINZESS (linaclotide), son produit commercialisé, est indiqué chez les hommes et les femmes adultes souffrant du syndrome du côlon irritable avec constipation (SCI-C) ou de constipation idiopathique chronique (CIC), ainsi que chez les patients pédiatriques âgés de 6 à 17 ans souffrant de constipation fonctionnelle (CF). Le linaclotide est disponible sous la marque CONSTELLA pour les hommes et les femmes adultes souffrant de SII-C ou de CIC, ainsi que pour les patients pédiatriques. La société s’engage également dans le développement de l’apraglutide, un analogue peptidique synthétique à action prolongée du peptide-2 de type glucagon (GLP-2), destiné aux patients atteints du syndrome de l’intestin court (SIC) et dépendant d’une alimentation parentérale.

Employés

100

Secteur

Produits pharmaceutiques

Plus d'informations sur la société